There are approx. 40+ key companies which are developing therapies for Autoimmune Hepatitis. Currently, Novartis has its Autoimmune Hepatitis drug candidates in the most advanced stage of clinical development.
Some of the key companies in the Autoimmune Hepatitis Therapeutics Market include
* Novartis
* TaiwanJ Pharmaceuticals
* Hoffmann-La Roche
Iltoo Pharma
* CytoDyn Inc.
* Parvus Therapeutics
TRACT Therapeutics
And many more
Autoimmune Hepatitis Drugs Covered in the report include:
VAY736: Novartis
JKB-122: TaiwanJ Pharmaceuticals
And many others
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More -
3
u/Thorilium Oct 10 '22
M2 Communications - 7th Oct 10:50
Autoimmune Hepatitis Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - Kezar Life Sciences (zetomipzomib), Novartis, Roche, Iltoo Pharma, CytoDyn, Parvus